![Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics](https://pubs.rsna.org/cms/10.1148/rg.2021210005/asset/images/medium/rg.2021210005.tbl1.png)
Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics
![HE4 can Help Discriminate Women with Malignant Ovarian Tumors only if CA125 Levels are Elevated - Denise da Rocha Pitta, Luis Otávio Sarian, Elisabete Aparecida Campos, Liliana Lucci De Angelo Andrade, Luis HE4 can Help Discriminate Women with Malignant Ovarian Tumors only if CA125 Levels are Elevated - Denise da Rocha Pitta, Luis Otávio Sarian, Elisabete Aparecida Campos, Liliana Lucci De Angelo Andrade, Luis](https://journals.sagepub.com/cms/10.5301/JBM.5000029/asset/images/large/10.5301_jbm.5000029-fig2.jpeg)
HE4 can Help Discriminate Women with Malignant Ovarian Tumors only if CA125 Levels are Elevated - Denise da Rocha Pitta, Luis Otávio Sarian, Elisabete Aparecida Campos, Liliana Lucci De Angelo Andrade, Luis
![Diagnostics | Free Full-Text | Evaluation of He4 Use in the Diagnosis of Ovarian Cancer: First and Second Recurrence, and an Analysis of HE4 Concentration during Second- and Third-Line Chemotherapy Diagnostics | Free Full-Text | Evaluation of He4 Use in the Diagnosis of Ovarian Cancer: First and Second Recurrence, and an Analysis of HE4 Concentration during Second- and Third-Line Chemotherapy](https://www.mdpi.com/diagnostics/diagnostics-13-00452/article_deploy/html/images/diagnostics-13-00452-g001-550.jpg)
Diagnostics | Free Full-Text | Evaluation of He4 Use in the Diagnosis of Ovarian Cancer: First and Second Recurrence, and an Analysis of HE4 Concentration during Second- and Third-Line Chemotherapy
![HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm | British Journal of Cancer HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm | British Journal of Cancer](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fsj.bjc.6606092/MediaObjects/41416_2011_Article_BF6606092_Fig4_HTML.jpg)
HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm | British Journal of Cancer
Performance of preoperative plasma tumor markers HE4 and CA125 in predicting ovarian cancer mortality in women with epithelial ovarian cancer | PLOS ONE
![PDF] Determination of the Reference Values of the Tumor Marker HE4 in Female Population of Canton Sarajevo | Semantic Scholar PDF] Determination of the Reference Values of the Tumor Marker HE4 in Female Population of Canton Sarajevo | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/f50dc44db73d02a0fdaecab49c845d96479f6e8f/3-Table2-1.png)
PDF] Determination of the Reference Values of the Tumor Marker HE4 in Female Population of Canton Sarajevo | Semantic Scholar
![The biomarker HE4 (WFDC2) promotes a pro-angiogenic and immunosuppressive tumor microenvironment via regulation of STAT3 target genes | Scientific Reports The biomarker HE4 (WFDC2) promotes a pro-angiogenic and immunosuppressive tumor microenvironment via regulation of STAT3 target genes | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-020-65353-x/MediaObjects/41598_2020_65353_Fig1_HTML.png)
The biomarker HE4 (WFDC2) promotes a pro-angiogenic and immunosuppressive tumor microenvironment via regulation of STAT3 target genes | Scientific Reports
![Comparison of Serum Human Epididymis Protein 4 with Cancer Antigen 125 as a Tumor Marker in Patients with Malignant and Nonmalignant Diseases J.M. Escudero, - ppt video online download Comparison of Serum Human Epididymis Protein 4 with Cancer Antigen 125 as a Tumor Marker in Patients with Malignant and Nonmalignant Diseases J.M. Escudero, - ppt video online download](https://slideplayer.com/slide/6626598/23/images/3/Introduction+%28cont%E2%80%99d%29.jpg)
Comparison of Serum Human Epididymis Protein 4 with Cancer Antigen 125 as a Tumor Marker in Patients with Malignant and Nonmalignant Diseases J.M. Escudero, - ppt video online download
![Reference ranges for HE4 and CA125 in a large Asian population by automated assays and diagnostic performances for ovarian cancer - Park - 2012 - International Journal of Cancer - Wiley Online Library Reference ranges for HE4 and CA125 in a large Asian population by automated assays and diagnostic performances for ovarian cancer - Park - 2012 - International Journal of Cancer - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/2487ea26-1e5f-4b40-9ecd-fddbb803589d/ntbl003.jpg)
Reference ranges for HE4 and CA125 in a large Asian population by automated assays and diagnostic performances for ovarian cancer - Park - 2012 - International Journal of Cancer - Wiley Online Library
![PDF) HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases | Jose Miguel Escudero - Academia.edu PDF) HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases | Jose Miguel Escudero - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/49394150/mini_magick20190131-26445-njjm3w.png?1548982026)
PDF) HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases | Jose Miguel Escudero - Academia.edu
![Reference ranges for HE4 and CA125 in a large Asian population by automated assays and diagnostic performances for ovarian cancer - Park - 2012 - International Journal of Cancer - Wiley Online Library Reference ranges for HE4 and CA125 in a large Asian population by automated assays and diagnostic performances for ovarian cancer - Park - 2012 - International Journal of Cancer - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/1e28ef43-c740-4fed-8a87-890cd2491360/ntbl004.jpg)
Reference ranges for HE4 and CA125 in a large Asian population by automated assays and diagnostic performances for ovarian cancer - Park - 2012 - International Journal of Cancer - Wiley Online Library
![SciELO - Brasil - A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses A comparison of CA125, HE4, risk ovarian SciELO - Brasil - A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses A comparison of CA125, HE4, risk ovarian](https://minio.scielo.br/documentstore/1980-5322/33NknbMHmXvr6ysnZjDL7Vd/7240101f361005f36d10165d48e3ababed511b16.jpg)
SciELO - Brasil - A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses A comparison of CA125, HE4, risk ovarian
![PDF] No benefit from combining HE4 and CA125 as ovarian tumor markers in a clinical setting. | Semantic Scholar PDF] No benefit from combining HE4 and CA125 as ovarian tumor markers in a clinical setting. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/7968dca1873e681e0be5dd4a14690d730da0e0b2/4-Table1-1.png)